Health-System Edition March 2021

Pharmacists can lead to the charge to innovate in both 503A and 503B settings, which are poised to change and grow.

Developing an antimicrobial stewardship program is arduous but valuable; commitment from leadership is the first step.

Empiric anti-MRSA therapy is an area of opportunity for antimicrobial stewardship in the treatment of CAP.

Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.

Modifications include high rates of neoadjuvant endocrine chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.

Thoughtful application can reduce resistance and improve overall operations, if consistent steps are followed.

Early recognition and treatment, along with a coordinated approach and multidisciplinary team, are important to limit disease progression.

The pharmacy community has stepped up mightily to ensure this massive health care effort is successful.

Digital health products and solutions expand ways to guide prevention and treatment.

Technology is essential, but not all solutions meet every goal or offer the same capabilities.

COVID-19 is fueling the expansion of treatment methods beyond medications to include digital therapeutics.